Pediatric Hematology-Oncology

Department
Pediatrics
Course Number
PED 386
Course Title Pediatric Hematology-Oncology
Course Director
Liny John, MD
Length (Weeks)

4

When Offered

All year

Prerequisites

PED 303

Availability Notes
Contact Name
Wilhelmina Bradford
Contact Phone
Contact Fax
Contact Email
wcbradfo@childrensnational.org
Other Contacts

Course Director Dr. Liny John (ljohn [at] childrensnational.org (ljohn[at]childrensnational[dot]org)); Course Co-Director Dr. Jennifer Webb (JWebb [at] childrensnational.org (JWebb[at]childrensnational[dot]org))

Location

Children’s National Hospital, 4 East

Limit
1
Report

Students will be sent information prior to rotation.

Evaluation

Uniform Clinical Evaluation

Description

Students will be exposed to the outpatient diagnosis and management of children with hematologic and oncologic diseases. The student will work with different fellows and attendings based on their specialty focus. Examples include clinics focused on general hematology, sickle cell, bleeding disorders, thrombosis, blood cancers, solid tumors and brain tumors. Laboratory experiences include examination of peripheral blood smears and bone marrow aspirates, as well as the interpretation of laboratory tests used in the diagnosis and management of these patients. A shadowed inpatient experience can be provided based on student interest. No call or weekend hours are required. The outpatient portion does not provide regular working exposure to residents; however, regular attendance at resident conferences is encouraged.

Course Learning Objectives:

By the end of this course, the student should be able to:

  1. Recognize signs and symptoms concerning for a new hematologic or oncologic disease that would require sub-specialty follow up.
  2. Interpret laboratory tests used in the diagnosis and management of pediatric patients with hematologic and oncologic diseases.
  3. Describe clinical care and management that enhances the health and well-being of children with the most common hematologic and oncologic diseases.
Additional Notes